TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
D.S. Pharma Consulting AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
181
|
195 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
11
|
2 | |
| EBITDA |
12
|
2 | |
| Total assets |
52
|
60 | |
| Current assets |
52
|
60 | |
| Current liabilities |
24
|
29 | |
| Equity capital |
17
|
31 | |
| - share capital |
8
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
32.7%
|
51.7% | |
| Turnover per employee |
90
|
98 | |
| Profit as a percentage of turnover |
6.1%
|
1.0% | |
| Return on assets (ROA) |
23.1%
|
3.3% | |
| Current ratio |
216.7%
|
206.9% | |
| Return on equity (ROE) |
64.7%
|
6.5% | |
| Change turnover |
4
|
29 | |
| Change turnover % |
6%
|
2%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.